Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology

Health-care professionals who prescribe medicines have the professional duty to choose medicines that are in the best interest of their individual patient, irrespective if that patient is an adult or a child. However, the availability of medicines with an appropriate label for pediatric use is laggi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of pediatrics 2020-05, Vol.179 (5), p.839-847
Hauptverfasser:	Schrier, Lenneke, Hadjipanayis, Adamos, Stiris, Tom, Ross-Russell, Rob I, Valiulis, Arunas, Turner, Mark A, Zhao, Wei, De Cock, Pieter, de Wildt, Saskia N, Allegaert, Karel, van den Anker, John
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Child Child, Preschool Children EAP Statement Europe Female Health care Humans Infant Infant, Newborn Infants Male Medicine Medicine & Public Health Neonates Newborn babies Off-Label Use - standards Patients Pediatrics Pediatrics - methods Pediatrics - standards Practice Patterns, Physicians' - standards Professionals Societies, Medical Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!